JAMES GLEASON: Open Payments
NPI 1780649368 · RIVERDALE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$891 in 32 payments from 11 companies in 2025. Trend: 2023 $710 · 2024 $1,056 · 2025 $891
Food & beverage: $891
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $223 |
| ABBVIE INC. | 9 | $203 |
| ViiV Healthcare Company | 6 | $149 |
| Lilly USA, LLC | 2 | $118 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $71 |
| Novo Nordisk Inc | 1 | $26 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $20 |
| Exact Sciences Corporation | 1 | $17 |
Products named: JARDIANCE, BREZTRI, DOVATO, UBRELVY, VRAYLAR, AIRSUPRA, QULIPTA, CABENUVA.
Industry payments across GA — which companies pay providers there.
